179 related articles for article (PubMed ID: 33513571)
1. Standardization of cerebrospinal fluid shunt valves in pediatric hydrocephalus: an analysis of cost, operative time, length of stay, and shunt failure.
Berns J; Priddy B; Belal A; Seibold RD; Zieles K; Jea A
J Neurosurg Pediatr; 2021 Jan; 27(4):400-405. PubMed ID: 33513571
[TBL] [Abstract][Full Text] [Related]
2. Adjustable vs set-pressure valves decrease the risk of proximal shunt obstruction in the treatment of pediatric hydrocephalus.
McGirt MJ; Buck DW; Sciubba D; Woodworth GF; Carson B; Weingart J; Jallo G
Childs Nerv Syst; 2007 Mar; 23(3):289-95. PubMed ID: 17106749
[TBL] [Abstract][Full Text] [Related]
3. The programmable adult Codman Hakim valve is useful even in very small children with hydrocephalus. A 7-year retrospective study with special focus on cost/benefit analysis.
Arnell K; Eriksson E; Olsen L
Eur J Pediatr Surg; 2006 Feb; 16(1):1-7. PubMed ID: 16544218
[TBL] [Abstract][Full Text] [Related]
4. The Preventable Shunt Revision Rate: a potential quality metric for pediatric shunt surgery.
Venable GT; Rossi NB; Morgan Jones G; Khan NR; Smalley ZS; Roberts ML; Klimo P
J Neurosurg Pediatr; 2016 Jul; 18(1):7-15. PubMed ID: 26966884
[TBL] [Abstract][Full Text] [Related]
5. A randomized, controlled study of a programmable shunt valve versus a conventional valve for patients with hydrocephalus. Hakim-Medos Investigator Group.
Pollack IF; Albright AL; Adelson PD
Neurosurgery; 1999 Dec; 45(6):1399-408; discussion 1408-11. PubMed ID: 10598708
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for repeated cerebrospinal shunt failures in pediatric patients with hydrocephalus.
Tuli S; Drake J; Lawless J; Wigg M; Lamberti-Pasculli M
J Neurosurg; 2000 Jan; 92(1):31-8. PubMed ID: 10616079
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial of cerebrospinal fluid shunt valve design in pediatric hydrocephalus.
Drake JM; Kestle JR; Milner R; Cinalli G; Boop F; Piatt J; Haines S; Schiff SJ; Cochrane DD; Steinbok P; MacNeil N
Neurosurgery; 1998 Aug; 43(2):294-303; discussion 303-5. PubMed ID: 9696082
[TBL] [Abstract][Full Text] [Related]
8. Comparative durability and costs analysis of ventricular shunts.
Agarwal N; Kashkoush A; McDowell MM; Lariviere WR; Ismail N; Friedlander RM
J Neurosurg; 2018 May; 130(4):1252-1259. PubMed ID: 29749912
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with 30-day ventriculoperitoneal shunt failure in pediatric and adult patients.
Anderson IA; Saukila LF; Robins JMW; Akhunbay-Fudge CY; Goodden JR; Tyagi AK; Phillips N; Chumas PD
J Neurosurg; 2018 Mar; 130(1):145-153. PubMed ID: 29521592
[TBL] [Abstract][Full Text] [Related]
10. From fixed-pressure paediGAV to programmable proGAV/proSA serial valves for pediatric hydrocephalus within the 1st year of life: a technical single-center analysis.
Teping F; Huelser M; Sippl C; Zemlin M; Oertel J
J Neurosurg Pediatr; 2023 Jun; 31(6):536-544. PubMed ID: 36933264
[TBL] [Abstract][Full Text] [Related]
11. Comparison of programmable shunt valves vs standard valves for communicating hydrocephalus of adults: a retrospective analysis of 407 patients.
Ringel F; Schramm J; Meyer B
Surg Neurol; 2005 Jan; 63(1):36-41; discussion 41. PubMed ID: 15639519
[TBL] [Abstract][Full Text] [Related]
12. Silver-impregnated, antibiotic-impregnated or non-impregnated ventriculoperitoneal shunts to prevent shunt infection: the BASICS three-arm RCT.
Mallucci CL; Jenkinson MD; Conroy EJ; Hartley JC; Brown M; Moitt T; Dalton J; Kearns T; Griffiths MJ; Culeddu G; Solomon T; Hughes D; Gamble C;
Health Technol Assess; 2020 Mar; 24(17):1-114. PubMed ID: 32238262
[TBL] [Abstract][Full Text] [Related]
13. PROSAIKA: a prospective multicenter registry with the first programmable gravitational device for hydrocephalus shunting.
Kehler U; Kiefer M; Eymann R; Wagner W; Tschan CA; Langer N; Rohde V; Ludwig HC; Gliemroth J; Meier U; Lemcke J; Thomale UW; Fritsch M; Krauss JK; Mirzayan MJ; Schuhmann M; Huthmann A
Clin Neurol Neurosurg; 2015 Oct; 137():132-6. PubMed ID: 26196478
[TBL] [Abstract][Full Text] [Related]
14. Early programmable valve malfunctions in pediatric hydrocephalus.
Mangano FT; Menendez JA; Habrock T; Narayan P; Leonard JR; Park TS; Smyth MD
J Neurosurg; 2005 Dec; 103(6 Suppl):501-7. PubMed ID: 16383248
[TBL] [Abstract][Full Text] [Related]
15. Seven years of clinical experience with the programmable Codman Hakim valve: a retrospective study of 583 patients.
Zemack G; Romner B
J Neurosurg; 2000 Jun; 92(6):941-8. PubMed ID: 10839253
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with early shunt revision within 30 days: analyses from the National Surgical Quality Improvement Program.
Alvi MA; Bhandarkar AR; Daniels DJ; Miller KJ; Ahn ES
J Neurosurg Pediatr; 2022 Jan; 29(1):21-30. PubMed ID: 34624850
[TBL] [Abstract][Full Text] [Related]
17. Ventriculo-peritoneal shunting devices for hydrocephalus.
Garegnani L; Franco JV; Ciapponi A; Garrote V; Vietto V; Portillo Medina SA
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD012726. PubMed ID: 32542676
[TBL] [Abstract][Full Text] [Related]
18. The delta valve: how does its clinical performance compare with two other pressure differential valves without antisiphon control?
Davis SE; Levy ML; McComb JG; Sposto R
Pediatr Neurosurg; 2000 Aug; 33(2):58-63. PubMed ID: 11070430
[TBL] [Abstract][Full Text] [Related]
19. The treatment of infantile hydrocephalus: "differential-pressure" or "flow-control" valves. A pilot study.
Jain H; Sgouros S; Walsh AR; Hockley AD
Childs Nerv Syst; 2000 Apr; 16(4):242-6. PubMed ID: 10855523
[TBL] [Abstract][Full Text] [Related]
20. Change in ventricular size and effect of ventricular catheter placement in pediatric patients with shunted hydrocephalus.
Tuli S; O'Hayon B; Drake J; Clarke M; Kestle J
Neurosurgery; 1999 Dec; 45(6):1329-33; discussion 1333-5. PubMed ID: 10598700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
